ArticleBiomedicines2026

Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis.

Biljana Stankovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.